Office of the Revisor of Statutes

HF 3664

Status in the House - 93rd Legislature (2023 - 2024)

Current bill text: As Introduced
Add HF3664 to MyBills
Version List

Companion: SF4058
Companion Text
Senate Search

Revisor number: 24-06362

Long Description

Further Committee Actions

House Research Summary
Fiscal Notes

Engrossments
Introduction PDF	Posted on 02/13/2024

Description

Commissioner of human services authorized to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases.

Authors (4)

Actions

House

02/13/2024	Introduction and first reading, referred to Health Finance and Policy pg. 11207 Intro
02/26/2024	Author added Reyer pg. 11475
03/13/2024	Author added Nadeau pg. 11852
03/18/2024	Author added Hemmingsen-Jaeger pg. 12002

House Actions	Senate Actions
02/13/2024
Introduction and first reading, referred to Health Finance and Policy pg. 11207 Intro
02/26/2024
Author added Reyer pg. 11475
03/13/2024
Author added Nadeau pg. 11852
03/18/2024
Author added Hemmingsen-Jaeger pg. 12002